SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (3186)12/8/1997 2:02:00 AM
From: George T. Santamaria  Respond to of 6136
 
<o, to say Viracept was a compound found in a LLY compound library and hence
not a tribute to AGPH's drug discovery/design expertise is inaccurate.>

Let me add to this point by saying that among researchers, the ability to identify promising commercial targets for development is a rarer skill than the ability to invent them. AGPH was somewhat lucky and quite smart to walk away from the collaboration with something that really works.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News